LATP hits harder: +5.7% GG≥2 vs TRUS (p=0.031)! Fewer infections, slightly more pain & embarrassment. No abx needed. Costlier, slower—but sharper. #TRANSLATEtrial #ProstateCancer #LATP #TRUS #EAU25 #LancetOncology @axelmerseburger.bsky.social

Just out in @bmj.com, our "Uncertainties in Practice" article on #LATP vs #TRUS

We highlight evidence so far, discordance between recommendations (@UroWeb.bsky.social vs @NIHR.bsky.social vs #AUA) & need for nuance (!)

Not long now until #TranslateTrial...

bmj.com/content/387/bm…👈